Hemispherx Biopharma (HEB) Announces Compliance with NYSE Continued Listing Standards
- BAT Reaches Deal to Acquire Reynolds American (RAI) for $49 Billion
- Trump, Brexit uncertainty hit stocks and dollar, gold jumps
- Noble Energy (NBL) to Acquire Clayton Williams Energy (CWEI) for $2.7B in Cash and Stock
- UnitedHealth Group (UNH) Tops Q4 EPS by 4c; Affirms Outlook
- Oil rises on weaker dollar, Saudi commitment to cut output
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Hemispherx Biopharma (NYSE: HEB) announced today that, based on a notice received on September 15, 2016 from the New York Stock Exchange, Inc., the Company has regained compliance with the NYSE MKT’s continued listing standards set forth in Part 10 of the NYSE MKT Company Guide.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer Patients
- Carnegie Still Interested in magicJack VocalTec (CALL) Bid
- UPDATE: Uranium Energy (UEC) Files to Offer 6.7M Common Stock and Warrant Units
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!